Skip to main content

Irritable Bowel Syndrome

Gastro Learning Network
May 20, 2020
In a new study, researchers sought to clarify how the gut microbe may influence chronic gastrointestinal disease. The coauthors Michael C. Hoaglin, MD and Melissa Agnello, PhD answered our questions about their research.
Gastro Learning Network
March 31, 2020
Joshua Z. Goldenberg, ND, answered our questions about his team’s study aimed to assess the efficacy and safety of biofeedback-based interventions for treating irritable bowel syndrome among adults and children.
Gastro Learning Network
March 10, 2020
Maitreyi Raman, MD, MSc, answers our questions about how the low FODMAP diet affects irritable bowel syndrome symptoms, concerns about prescribing the low FODMAP diet, and factors that need to be considered before prescribing the low FODMAP diet.
Gastro Learning Network
January 06, 2020
Dr Pimentel, from Cedars-Sinai, discusses the current challenges of IBS management, how food poisoning and a low fermentation diet impact the disease, promising strategies for the future, and more.
Gastro Learning Network
December 17, 2019
See how much you know about irritable bowel syndrome by taking this short quiz based on facts from the National Institute of Diabetes and Digestive and Kidney Diseases.
Gastro Learning Network
December 09, 2019
Michael Camilleri, MD, from the Mayo Clinic, answers our questions about his research on fecal bile acids and fecal fat as potential biomarkers for irritable bowel syndrome, the importance of individualized treatment, and more.
Gastro Learning Network
November 18, 2019
Which psychological intervention do you most often recommend to patients with IBS seen in your practice? Let us know by taking our poll!
Gastro Learning Network
November 18, 2019
Magnus Simrén, MD, PhD, answers our questions about his research that assessed whether human milk oligosaccharides could improve bowel symptoms in patients with irritable bowel syndrome.
Gastro Learning Network
November 07, 2019
Dr Brenner, from Northwestern Medicine, discusses the current management of IBS, findings from the RELIEF phase 4 clinical trial of IBS-D, why targeting underlying pathogenic mechanisms of IBS symptoms is the future of management, and more.
Gastro Learning Network
October 23, 2019
Authors of a new study determined whether patients with irritable bowel syndrome could experience symptom relief with fecal microbiota transplantation from a single donor with a favorable microbiota profile. The findings were presented at UEG Week 2019.
Back to Top